peptideone
← All peptides

Thymogen

Status unknown

Also known as: Oglufanide, 38101-59-6, Glutamyltryptophan, L-Tryptophan, L-alpha-glutamyl-, alpha-Glu-Trp, L-alpha-Glu-L-Trp, oglufanida, 4RHY598T5U

Thymogen (Oglufanide, 38101-59-6, Glutamyltryptophan) is classified under repair & thymosin peptides.

What the research says

Aggregated from the cited literature below. We summarize sources — we don't author claims.

Thymogen (also referred to as Oglufanide; L-Glu-L-Trp) is discussed in the provided sources as a chiral dipeptide with reported immunomodulatory and experimental tissue effects. Research topics in the sources include chirality/enantiomer comparison, oxidative stress/reparative responses in liver injury models, and effects on radiation- or carcinogen-induced tumor development in rodents. A separate review source summarizes authors’ long-term clinical studies using “peptide bioregulators,” including Thymogen.

Key findings (each cites a source)

  • A review reported chirality as a factor in peptide/protein interactions and discussed Thymogen as an immunostimulant (L-Glu-L-Trp) in comparison with the enantiomeric immunosuppressor Thymodepressin (D-Glu(D-Trp)). [PMID 38732260]
  • Research in an acute toxic hepatopathy model reported that Thymogen and D-Ala–modified analogues suppressed oxidative peroxidation and stimulated reparative regeneration of hepatocytes. [PMID 37861903]
  • In the liver damage model, the reported effects of Thymogen analogues were more pronounced than Thymogen, and D-Ala inclusion was reported to enhance regeneration and antioxidant effects, with highest efficiency reported when D-Ala was added to the C-end. [PMID 37861903]
  • A rat hepatopathy study reported that thymogen and thymogen analogues with D-alanine attached to the N- or C-terminus inhibited lipid peroxidation and stimulated reparative regeneration of hepatocytes. [PMID 40442470]
  • In that hydrazine hepatopathy study, the thymogen analogue reported as most effective was the version with D-Ala at the C-terminus, and increasing the doses beyond stated levels was reported not to further increase hepatoprotective activity. [PMID 40442470]
  • In female rat experiments investigating radiation-induced carcinogenesis, a study reported that thymogen inhibited Sr-90/Cs-137-induced radiation carcinogenesis, with decreased total tumor and cancer occurrence, and that thymogen alone was associated with longer life span and lower overall tumor/cancer occurrence in the study design. [PMID 1300740]
  • In experimental studies of acute abdominal disorders in rats, research reported thymogen-associated reductions in indicators such as autoenzyme aggression (serum alpha-amylolytic activity) and lipid peroxidation products (malonic dialdehyde), alongside reported attenuation of depression of antiradical activity (superoxide dismutase and catalase) and reduced leukocytosis/leukocyte intoxication index compared with untreated animals. [PMID 9542399]
  • In candidiasis under immunodepression, experimental work reported that after thymogen injections the course of candidiasis proceeded less severely, suggesting activation of an immunocompetent system including thymus in that model. [PMID 2337388]
  • In a study of esophageal and forestomach tumor development induced by N-nitrososarcosine ethyl ester in rats, thymogen was reported to decrease tumor incidence and reduce tumor multiplicity, while a comparator polypeptide drug was reported not to influence tumor development. [PMID 2759010]
  • A review summarized authors’ long-term “clinical study results” regarding peptide bioregulators (including Thymogen) for prevention of diseases and treatment of people of different ages, with emphasis on use as “geroprotectors.” [PMID 24003726]

Independent test grades

No independent third-party test data is available for Thymogen yet. Our test grades are aggregated from Finnrick, which independently tests a subset of research peptides — many approved drugs and newer or niche compounds aren't covered.

Research literature (8)

Consolidated from PubMed — each links to the original record.

FAQ

What is Thymogen?
Thymogen (Oglufanide, 38101-59-6, Glutamyltryptophan) is classified under repair & thymosin peptides. Research goals associated with it include immune support.
Is Thymogen FDA-approved?
The regulatory status of Thymogen is not established in our sources.
What does the research on Thymogen say?
peptideone aggregates 8 references from PubMed for Thymogen. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.
Aggregated from public sources, with attribution. Not medical advice; compounds discussed are not approved for human consumption. Last updated 2026-06-15.